Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
y. hadidene (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), A. Slim (Ariana, Tunisia), A. Saidani (Ariana, Tunisia), H. Bellali (Ariana, Tunisia), H. Ben Abdelghaffar (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), D. Greb (Ariana, Tunisia), H. Hela (Ariana, Tunisia), L. Fkih (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia). Performance status and body mass index : prognosis impact of their changes in patients with stage III NSCLC. 1639

Member's Comments

No comment yet.

Related content which might interest you: Body mass index in early stage lung cancer – should we be vigilant? Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 Influence of the body mass index on the survival of COPD patients Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI) Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 Staging COPD with body mass index and fat free mass index: relations with parameters expressing disease severity Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Influence of body weight and fat mass on pulmonary function and performance status of COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 The relation of body mass index to survival and respiratory function in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Association of weight loss in COPD patients with low body mass index on outcomes Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011 Assessment of relation between BODE index and quality of life, nutritional status, and C-reactive protein in patients with COPD Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007 Impact of poor performance status of the treatment of small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 The effect of nutritional support on pulmonary rehabilitation outcomes in COPD patients with low body mass index Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients Year: 2018 The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Influence of gender and age on correlation between body mass index and lung function in COPD Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Performance status as predictor factor of quality of life in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 The diagnostic value of leptin in progression of GOLD III COPD in patients with excessive body weight Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021